IPP Bureau
Healthcare Triangle launches in Singapore; Leveraging AI and cloud in Asia Pacific Markets
By IPP Bureau - July 26, 2022
The region's digital health market, valued at USD 40.3 billion in 2021, is expected to expand to USD 326.7 billion by 2030 at a CAGR of 26.5 per cent.
Suven Life Sciences posts Q1FY23 consolidated loss at Rs. 16.32 Cr
By IPP Bureau - July 26, 2022
Suven Life Sciences has reported total income of Rs. 3.97 crores during the period ended June 30, 2022
Sanofi India Q2 CY2022 PAT drops 49.5% to Rs. 120.4 Cr
By IPP Bureau - July 26, 2022
Sanofi India has reported total income of Rs. 715 crores during the period ended June 30, 2022.
Zydus receives final approval from the USFDA for Bisoprolol Fumarate Tablets
By IPP Bureau - July 26, 2022
Bisoprolol Fumarate Tablets are used to treat high blood pressure.
Sun Pharma and Cosmo announce territory expansion of license and supply agreements for WINLEVI
By IPP Bureau - July 26, 2022
Sun Pharma will receive from Cassiopea the exclusive right to develop and commercialize WINLEVI in Japan, Australia, New Zealand, Brazil, Mexico and Russia.
Dabur launches 'Dabur Himalayan Shilajit'
By IPP Bureau - July 26, 2022
Funds for R&D in drug discovery and manufacturing :PIB
By IPP Bureau - July 26, 2022
An outlay of Rs. 1,500 crore has been approved for strengthening/ up-gradation of these NIPERs for the period 2021-22 to 2025-26.
Bug Bite Thing partnership with certified pediatrician Dr. Mona Amin
By IPP Bureau - July 25, 2022
Dr. Mona frequently treats children experiencing localized reactions from insect bites and stings.
WuXi STA opens a new large scale continuous manufacturing plant at Changzhou site
By IPP Bureau - July 24, 2022
WuXi STA opens a new large scale continuous manufacturing plant
WuXi AppTec plans to build a new site in Singapore
By IPP Bureau - July 24, 2022
Better serving global partners and advancing healthcare innovation
FDA approval of deep brain stimulators will drive APAC market, says GlobalData
By IPP Bureau - July 24, 2022
Abbott has recently received the US Food and Drug Administration nod to use its DBS device for treatment-resistant depression
Import of Medical Devices Up by Record 41% in FY22: AiMeD
By IPP Bureau - July 24, 2022
India imported medical devices worth Rs. 63,200 crore in 2021-22, up 41% from Rs. 44,708 crore in 2020-21
Merck opens microbiology application lab in Jigani, Bengaluru
By IPP Bureau - July 24, 2022
Merck’s first microbiology application and training lab in India
SMS Pharmaceuticals receives approval for Ibuprofen by EDQM
By IPP Bureau - July 24, 2022
With this, the company can start selling Ibuprofen in the European markets.
Dr. Reddy's announces the first-to-market, OTC launch of Allegra-D in the US market
By IPP Bureau - July 24, 2022
Allegra-D had U.S. retail sales of approximately $45 million as of May 2022 according to IRI.
